205 related articles for article (PubMed ID: 6218391)
1. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
Roberts D; Franklin P; Odom G; Peck C; Chwang TL
Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
[TBL] [Abstract][Full Text] [Related]
2. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
Armstrong RD; Diasio RB
Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
[No Abstract] [Full Text] [Related]
5. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
6. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
[TBL] [Abstract][Full Text] [Related]
7. Assay of intracellular thymidylate synthetase activity and inhibition by 5-fluoro-2'-deoxyuridine in lymphocytes.
Cox S; Harmenberg J
J Biochem Biophys Methods; 1992 Aug; 25(1):17-23. PubMed ID: 1430788
[TBL] [Abstract][Full Text] [Related]
8. Levels of thymidylate synthetase during normal culture growth of L1210 cells.
Cadman E; Heimer R
Cancer Res; 1986 Mar; 46(3):1195-8. PubMed ID: 3943093
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.
Ullman B; Lee M; Martin DW; Santi DV
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):980-3. PubMed ID: 147465
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mammalian tumour thymidylate synthetase by 2'-deoxyuridine 5'-phosphate analogues.
Rode W; Kulikowski T; Kedzierska B; Shugar D
Drugs Exp Clin Res; 1986; 12(6-7):545-9. PubMed ID: 3743372
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluoro-5'-deoxyuridine is an inhibitor of uridylate nucleotidase in L1210 leukaemia.
Roobol C; De Dobbeleer GB; Bernheim JL
Adv Exp Med Biol; 1986; 195 Pt B():177-83. PubMed ID: 3020904
[No Abstract] [Full Text] [Related]
12. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
Balzarini J
Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
[No Abstract] [Full Text] [Related]
13. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
14. 5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in culture.
Cory JG; Halley MC; Jeney A; Lapis K
Cancer Res; 1990 Aug; 50(15):4552-6. PubMed ID: 2142444
[TBL] [Abstract][Full Text] [Related]
15. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
16. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
Davis ST; Berger SH
Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration.
Kawaguchi T; Saito M; Saneyoshi M
J Pharm Sci; 1988 Nov; 77(11):939-43. PubMed ID: 2976090
[TBL] [Abstract][Full Text] [Related]
18. The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells.
Danenberg PV; Heidelberger C; Mulkins MA; Peterson AR
Biochem Biophys Res Commun; 1981 Sep; 102(2):654-8. PubMed ID: 6458299
[No Abstract] [Full Text] [Related]
19. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
Washtien WL
Mol Pharmacol; 1982 May; 21(3):723-8. PubMed ID: 6213845
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
FitzGerald GB; Ratliff J; Wick MM
Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
